Table 1 Patient characteristics
n | ||
|---|---|---|
Sex | Females | 82 (42.1%) |
Age | Mean (SD) | 64 (10.03) |
BMI (kg/m2) | Mean (SD) | 26.21 (4.03) |
CCI | 2 | 142 (72.8%) |
3 | 42 (21.6%) | |
> 3 | 11 (5.6%) | |
Clinical stage prior to treatment | II | 58 (29.7%) |
III | 137 (70.3%) | |
Neoadjuvant therapy | RT | 127 (65.1%) |
CRT | 68 (34.9%) | |
Time RT-S > = 6 weeks | Yes | 107 (54.9%) |
Distance from the anal verge (cm) | 1–5 | 57 (29.2%) |
6–10 | 93 (47.7%) | |
11–15 | 45 (23.1%) | |
Loop ileostomy | Yes | 41 (21%) |
yG | 1 | 16 (8.2%) |
2 | 111 (57.2%) | |
x | 67 (34.5%) | |
ypT | 0 | 17 (8.7%) |
1-2 | 98 (50.3%) | |
3 | 80 (41%) | |
LNY | Mean (SD) | 12.16 (6.01) |
LNY groups | 1–7 | 45 (23.1%) |
8–12 | 72 (36.9%) | |
> 12 | 78 (40%) | |
Width of the distal margin (cm) | Mean (SD) | 2.13 (1.41) |
TRG | 0–1 | 91 (46.7%) |
2–3 | 104 (53.3%) | |
Anastomotic leakage | No | 158 (81%) |
Early | 22 (11.3%) | |
Late | 15 (7.7%) | |
Adjuvant chemotherapy | Yes | 16 (8.2%) |